JPRN-UMIN000011616已完成未知
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study - Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •i) severe systemic or uncontrolled disease (uncontrolled diabetes mellitus or hypertension) ii) asymptomatic metastases to the brain iii) seizure disorder requiring anticonvulsants unless clinically stable iv) uncontrolled pleural effusion or ascites v) gastric outlet or intestinal obstruction vi) a known hypersensitivity to palonosetron, granisetron, or other 5-HT3-receptor antagonists or dexamethasone ingredients. In the period between registration of patients and administration of the study drug, patients who met the following discontinuation criteria were withdrawn from the study
研究者
相似试验
已完成
不适用
The effect of Palonosetron for the prevention of postoperative nausea and vomitingKCT0000581Soon Chun Hyang University Hospital Seoul214
尚未招募
不适用
Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomitting in patients with haematological malignancieshaematological malignanciesJPRN-UMIN000005733Tokushima University Hospital50
已完成
2 期
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and VomitingNauseaVomitingChemotherapyNCT00503386Hangzhou Jiuyuan Gene Engineering Co. Ltd.,144
进行中（未招募）
不适用
Phase II study with Palonosetron alone in preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy - Palonosetron in NHpreventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy.MedDRA version: 9.1Level: HLTClassification code 10028817Term: Nausea and vomiting symptomsEUCTR2006-003189-33-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
已完成
2 期
The study of efficacy and safety of palonosetron for high-risk chemotherapy induced nausea and vomiting in malignant lymphoma.Malignant lymphomaJPRN-UMIN000008966Shimane University Hospital,cancer center54